Skip to content

Task-oriented Training for Stroke: Impact on Function Mobility

Task-oriented Training for Stroke: Impact on Function Mobility

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01322607
Acronym
TOTS
Enrollment
20
Registered
2011-03-24
Start date
2011-07-31
Completion date
2015-01-31
Last updated
2016-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular Accident, Stroke

Keywords

Exercise, Rehabilitation, Stroke

Brief summary

Residual neurological deficits from stroke lead to gait inefficiencies, resulting in an extremely high energy cost of movement and contributing to overall disability and lower quality of life. Therefore, interventions targeting movement economy should be developed for those in the chronic phase of stroke recovery. This study is designed to compare the effect of two distinctly different exercise paradigms (a higher-intensity treadmill training program and a lower-intensity group exercise program) on economy of movement during over-ground walking and activities of daily living, as well as the extent to which gains in muscular strength, muscular endurance, and balance predict changes in movement economy.

Interventions

BEHAVIORALHigh-intensity Treadmill Exercise

High-intensity treadmill walking program

BEHAVIORALLow-intensity Lifestyle Intervention

A low-intensity lifestyle intervention targeted towards group exercises incorporating balance, coordination, and strength.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Stroke \> 6 months prior with residual hemiparetic gait in women or men aged 40-85 years. * Completion of all regular post-stroke physical therapy * Adequate language and neurocognitive function to participate in testing and training and to give adequate informed consent. * Able to rise from a chair unaided. * Able to walk 10 meters without human assistance.

Exclusion criteria

* Regular structured aerobic exercise (\> 2x week). * Alcohol consumption \> 3 oz. liquor, or 3 x 4 oz glasses of wine, or 3 x 12 oz. beers per day, by self-report. * Clinical history of * unstable angina, * recent (\< 3 months) myocardial infarction or congestive heart failure (NYHA category II), * hemodynamically significant valvular dysfunction, * Peripheral Arterial Obstructive Disease with claudication, * major orthopedic, chronic pain, or non-stroke neuromuscular disorders restricting exercise, * pulmonary or renal failure, * poorly controlled hypertension (\>190/110), measured on at least two separate occasions * recent hospitalization for severe disease or surgery * severe or global receptive aphasia which confounds reliable testing and training. * Untreated major depression as documented by a Center for Epidemiological Studies-Depression score of \>16 and confirmed by clinical interview. * Pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Economy of Gait3 monthsOver-ground gait economy measured using a portable metabolic monitoring system, K4b2 during a 6 minute walk, with subjects walking at their comfortable self-selected walking speed while open circuit spirometry collects break-by-break data. The K4b2 consists of a small battery pack and portable gas analyser (weighing less than 1 kg) that participants wear on their chest. Attached to the portable system is a flexible rubber facemask with flowmeter used for breath-by-breath analysis. The mean rate of oxygen consumption (VO2) will be calculated based on the final 3 minutes of a 6-minute walk under steady state oxygen consumption conditions. A 6 minute walk is a distance most representative of community-based ambulatory capacity and is a sensitive outcome measure in exercise studies in chronic stroke subjects. The higher the VO2 used during the 6 minute walk, represents a less efficient economy of gait.

Secondary

MeasureTime frameDescription
Muscular Strength3 monthsStrength measured by torque of isokinetic maximal concentric knee extensor volitional contractions of paretic and non-paretic leg at multiple angular velocities (30, 90, and 120°/sec). The higher the number the higher the muscular strength. Also performed on resistance equipment for both the Leg Press and Leg Extension. The higher the number the stronger a person is.
Muscular Endurance3 monthsMuscular endurance performed on Leg Press and assessed by a force transducer, while seated. The longer the amount of time participant can maintain a force the better their muscular endurance.
Balance3 monthsDynamic Gait Index - another measure related to balance and general function. It includes items of walking while changing speed, turning the head, pivot turning, walking over and around obstacles, and stair climbing. This index ranges from 0 - 24, with 24 representing a high level of balance and general function (the higher the score the better the balance).

Countries

United States

Participant flow

Recruitment details

Hemiparetic stroke survivors (\>6 months) with residual hemiparetic gait in women/men aged 30-85 years who completed all therapy were recruited. They had to have adequate language and neurocognitive function, give adequate informed consent, able to rise from a chair unaided, and able to walk 10 meters without human assistance.

Participants by arm

ArmCount
Arm 1: High-Intensity Program
High-intensity treadmill-based exercise High-intensity Treadmill Exercise: High-intensity treadmill walking program
11
Arm 2: Low-Intensity Program
Low-intensity lifestyle intervention (group exercise) Low-intensity Lifestyle Intervention: A low-intensity lifestyle intervention targeted towards group exercises incorporating balance, coordination, and strength.
9
Total20

Baseline characteristics

CharacteristicArm 1: High-Intensity ProgramArm 2: Low-Intensity ProgramTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
4 Participants3 Participants7 Participants
Age, Categorical
Between 18 and 65 years
7 Participants6 Participants13 Participants
Age, Continuous59.36 years
STANDARD_DEVIATION 8.63
61.89 years
STANDARD_DEVIATION 9.03
60.5 years
STANDARD_DEVIATION 8.67
BMI29.57 kg/m2
STANDARD_DEVIATION 5.73
30.34 kg/m2
STANDARD_DEVIATION 7.53
29.92 kg/m2
STANDARD_DEVIATION 6.43
Height172.79 cm
STANDARD_DEVIATION 10.83
169.54 cm
STANDARD_DEVIATION 11.87
171.33 cm
STANDARD_DEVIATION 11.13
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
9 Participants6 Participants15 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
1 Participants3 Participants4 Participants
Region of Enrollment
United States
11 participants9 participants20 participants
Sex: Female, Male
Female
5 Participants6 Participants11 Participants
Sex: Female, Male
Male
6 Participants3 Participants9 Participants
Weight88.92 kg
STANDARD_DEVIATION 22.27
86.56 kg
STANDARD_DEVIATION 19.57
87.86 kg
STANDARD_DEVIATION 20.59

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
6 / 118 / 9
serious
Total, serious adverse events
1 / 110 / 9

Outcome results

Primary

Economy of Gait

Over-ground gait economy measured using a portable metabolic monitoring system, K4b2 during a 6 minute walk, with subjects walking at their comfortable self-selected walking speed while open circuit spirometry collects break-by-break data. The K4b2 consists of a small battery pack and portable gas analyser (weighing less than 1 kg) that participants wear on their chest. Attached to the portable system is a flexible rubber facemask with flowmeter used for breath-by-breath analysis. The mean rate of oxygen consumption (VO2) will be calculated based on the final 3 minutes of a 6-minute walk under steady state oxygen consumption conditions. A 6 minute walk is a distance most representative of community-based ambulatory capacity and is a sensitive outcome measure in exercise studies in chronic stroke subjects. The higher the VO2 used during the 6 minute walk, represents a less efficient economy of gait.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Arm 1: High-Intensity ProgramEconomy of Gait13.44 ml/kg/minStandard Deviation 3.15
Arm 2: Low-Intensity ProgramEconomy of Gait12.67 ml/kg/minStandard Deviation 3.51
Secondary

Balance

Dynamic Gait Index - another measure related to balance and general function. It includes items of walking while changing speed, turning the head, pivot turning, walking over and around obstacles, and stair climbing. This index ranges from 0 - 24, with 24 representing a high level of balance and general function (the higher the score the better the balance).

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Arm 1: High-Intensity ProgramBalance17.01 units on a scaleStandard Deviation 4.13
Arm 2: Low-Intensity ProgramBalance14.22 units on a scaleStandard Deviation 3.56
Secondary

Muscular Endurance

Muscular endurance performed on Leg Press and assessed by a force transducer, while seated. The longer the amount of time participant can maintain a force the better their muscular endurance.

Time frame: 3 months

ArmMeasureGroupValue (MEAN)Dispersion
Arm 1: High-Intensity ProgramMuscular EnduranceLeg Press Non-Paretic Leg67.55 secondsStandard Deviation 24.66
Arm 1: High-Intensity ProgramMuscular EnduranceLeg Press Paretic Leg41.63 secondsStandard Deviation 22.36
Arm 2: Low-Intensity ProgramMuscular EnduranceLeg Press Non-Paretic Leg67.22 secondsStandard Deviation 24.96
Arm 2: Low-Intensity ProgramMuscular EnduranceLeg Press Paretic Leg40.10 secondsStandard Deviation 28.12
Secondary

Muscular Strength

Strength measured by torque of isokinetic maximal concentric knee extensor volitional contractions of paretic and non-paretic leg at multiple angular velocities (30, 90, and 120°/sec). The higher the number the higher the muscular strength. Also performed on resistance equipment for both the Leg Press and Leg Extension. The higher the number the stronger a person is.

Time frame: 3 months

ArmMeasureGroupValue (MEAN)Dispersion
Arm 1: High-Intensity ProgramMuscular StrengthLeg Extension Non-Paretic Leg151.82 newtons (N)Standard Deviation 53.73
Arm 1: High-Intensity ProgramMuscular StrengthLeg Extension Paretic Leg101.36 newtons (N)Standard Deviation 55.64
Arm 1: High-Intensity ProgramMuscular StrengthLeg Press Non-Paretic Leg491.82 newtons (N)Standard Deviation 217.42
Arm 1: High-Intensity ProgramMuscular StrengthLeg Press Paretic Leg371.82 newtons (N)Standard Deviation 229.78
Arm 2: Low-Intensity ProgramMuscular StrengthLeg Press Paretic Leg295.56 newtons (N)Standard Deviation 170.67
Arm 2: Low-Intensity ProgramMuscular StrengthLeg Extension Non-Paretic Leg113.33 newtons (N)Standard Deviation 61.24
Arm 2: Low-Intensity ProgramMuscular StrengthLeg Press Non-Paretic Leg463.33 newtons (N)Standard Deviation 146.03
Arm 2: Low-Intensity ProgramMuscular StrengthLeg Extension Paretic Leg70.0 newtons (N)Standard Deviation 35.18

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026